Discharge Education in Diabetic Surgical Patients (DEDES)

January 10, 2025 updated by: Ganime Esra Soysal, Abant Izzet Baysal University

The Effects of Discharge Education on Patient Satisfaction and Diabetes Empowerment in Diabetic Surgical Patients

In the literature, it is seen that the discharge education given to patients with diabetes is especially focused on the effects of blood glucose control and self-efficacy, and there is no study examining the effects of discharge education on diabetes empowerment with a more general perspective in diabetes patients in surgical processes. In this context, the study was designed to examine the effects of diabetes-based personalised discharge education given to surgical patients on satisfaction and diabetes empowerment.

Study Overview

Status

Not yet recruiting

Conditions

Intervention / Treatment

Detailed Description

he population of the study consists of patients diagnosed with diabetes and undergoing surgery in the Surgical and Mixed service of Izzet Baysal Training and Research Hospital. The sample number of the experimental study, which was planned to be carried out between January 2025 and December 2026, was planned to include 100 patients with 0.05 error, 0.95 confidence interval and 0.85 power in the calculation made in the Gpower statistical programme based on previous studies. Considering that patients could leave the study for other reasons, it was decided to carry out the study by randomisation with 110 patients, which is 10% more.

Discharge Training Satisfaction Scale for Surgical Patients: It is a scale developed to measure the satisfaction of surgical patients with discharge training. It consists of 21 items in a five-point Likert structure and has been evaluated as a valid and reliable tool for measuring patient satisfaction. The scale covers factors such as discharge process, personal information, home care, infection monitoring and controls. The Cronbach α reliability coefficient was found to be 0.91, indicating that the scale is highly reliable Diabetes Empowerment Scale: It is a 5-point Likert-type scale consisting of 8 items. Turkish validity and reliability was carried out by Jahanpeyma et al. in 2020

Study Type

Interventional

Enrollment (Estimated)

110

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

  • Turkey
    • Merkez
      • Bolu, Merkez, Turkey, 14100
        • Abant Izzet Baysal University Faculty of Health Science

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • He's had an operation,
  • Over 18 years old,
  • Diagnosed with diabetes,
  • Conscious patients returning to the clinic after surgery, not intubated

Exclusion Criteria:

  • He's unconscious,
  • Referral to intensive care,
  • Patients who do not agree to participate in the study will be excluded from the study.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Standardised discharge training

Discharge training will be given according to the standard operation.

Scales to be applied:

Discharge Training Satisfaction Scale for Surgical Patients: It is a scale developed to measure the satisfaction of surgical patients with discharge training. It consists of 21 items in a five-point Likert structure and has been evaluated as a valid and reliable tool for measuring patient satisfaction. The scale covers factors such as discharge process, personal information, home care, infection monitoring and controls. Cronbach's α reliability coefficient was found to be 0.91, indicating that the scale is highly reliable Diabetes Empowerment Scale: It is a 5-point Likert-type scale consisting of 8 items. Turkish validity and reliability was carried out in 2020 by Jahanpeyma et al.
Experimental: Personalised Discharge training

In addition to the discharge training given according to the standard surgery, Personalised Discharge training will be given with a holistic patient perspective for diabetes.

Scales to be applied:

Discharge Training Satisfaction Scale for Surgical Patients: It is a scale developed to measure the satisfaction of surgical patients with discharge training. It consists of 21 items in a five-point Likert structure and has been evaluated as a valid and reliable tool for measuring patient satisfaction. The scale covers factors such as discharge process, personal information, home care, infection monitoring and controls. Cronbach's α reliability coefficient was found to be 0.91, indicating that the scale is highly reliable Diabetes Empowerment Scale: It is a 5-point Likert-type scale consisting of 8 items. Turkish validity and reliability was carried out in 2020 by Jahanpeyma et al.
Device: Personalised Discharge training
Discharge education also contributes to the empowerment of diabetic surgery patients in diabetes management. During the training process, patients will be informed about blood glucose control, diet, exercise and medication management.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Satisfaction with Discharge Training
Time Frame: through study completion, an average of 1 year

It will be measured with the Discharge Training Satisfaction Scale Specific to Surgical Patients.

Satisfaction will be measured with the 'Discharge Training Satisfaction Scale'. It consists of 21 items in a 5-point Likert scale. The scale does not contain negative items. The lowest score of 21 points and the highest score of 105 points can be obtained from the scale.
through study completion, an average of 1 year
diabetes empowerment
Time Frame: through study completion, an average of 1 year

The ability to manage the disease will be measured with the Diabetes Empowerment Scale.

There are 28 items in Diabetes Empowerment Scale. Five-point Likert type (1:

Strongly disagree, 5: Strongly agree), items 18,20,21,22,23,24,25,26 and 27 of this scale are under the sub-dimension of 'Self-awareness-managing psychological aspects of illness'; items 1,2,3,4,15,16,17 and 19 are under the sub-dimension of 'Ability to achieve goals'; items 5,6,7,8,9,10,11,12,13 and 14 are under the sub-dimension of 'Ability to set goals'.

The minimum score of the scale is 28 and the maximum score is 140. A score between 28-65 points indicates a low level of resilience, 66-103 indicates a medium level, and 104-140 indicates a high level of resilience.
through study completion, an average of 1 year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Abant Izzet Baysal University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

February 1, 2025

Primary Completion (Estimated)

December 31, 2025

Study Completion (Estimated)

January 30, 2026

Study Registration Dates

First Submitted

January 4, 2025

First Submitted That Met QC Criteria

January 10, 2025

First Posted (Actual)

March 25, 2025

Study Record Updates

Last Update Posted (Actual)

March 25, 2025

Last Update Submitted That Met QC Criteria

January 10, 2025

Last Verified

January 1, 2025

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • SBF-HMS-GES-05

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

The study data can be shared when requested by e-mail from the responsible author after the patient information is purified.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Personalised Discharge training

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Tanzania

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe